A Meta-Analysis and Indirect Comparison of Endothelin A Receptor Antagonist for Castration-Resistant Prostate Cancer.

about

Cancer and the metastatic substrate.Non-Adrenergic, Tamsulosin-Insensitive Smooth Muscle Contraction is Sufficient to Replace α1 -Adrenergic Tension in the Human Prostate.Autoantibodies Directed Against the Endothelin A Receptor in Patients With Benign Prostatic Hyperplasia.

P2860

Q37573461-6EE2FF2A-0A6E-4822-8520-68ADF78B8BE8 Q47997829-50B692ED-A144-4AB4-A269-17EE58B5FD5E Q48924237-6B1908E9-6186-41F6-8AF3-D4A4938FEA2C

P2860

A Meta-Analysis and Indirect Comparison of Endothelin A Receptor Antagonist for Castration-Resistant Prostate Cancer.

Item

http://www.wikidata.org/entity/Q35698539

description

2015 nî lūn-bûn

@nan

2015年の論文

@ja

2015年論文

@yue

2015年論文

@zh-hant

2015年論文

@zh-hk

2015年論文

@zh-mo

2015年論文

@zh-tw

2015年论文

@wuu

2015年论文

@zh

2015年论文

@zh-cn

name

A Meta-Analysis and Indirect C ...... ion-Resistant Prostate Cancer.

@ast

A Meta-Analysis and Indirect C ...... ion-Resistant Prostate Cancer.

@en

type

Item

label

A Meta-Analysis and Indirect C ...... ion-Resistant Prostate Cancer.

@ast

A Meta-Analysis and Indirect C ...... ion-Resistant Prostate Cancer.

@en

prefLabel

A Meta-Analysis and Indirect C ...... ion-Resistant Prostate Cancer.

@ast

A Meta-Analysis and Indirect C ...... ion-Resistant Prostate Cancer.

@en

P1476

A Meta-Analysis and Indirect C ...... ion-Resistant Prostate Cancer.

@en

P2093

Li-xiu Zhang

http://www.w3.org/2001/XMLSchema#string

Ming Chen

http://www.w3.org/2001/XMLSchema#string

Ping Qi

http://www.w3.org/2001/XMLSchema#string

Rui-xia Song

http://www.w3.org/2001/XMLSchema#string

Zhen-hua He

http://www.w3.org/2001/XMLSchema#string

Zhi-ping Wang

http://www.w3.org/2001/XMLSchema#string

P2860

Cancer statistics, 2015

The PRISMA statement for reporting systematic reviews and meta-analyses of studies that evaluate healthcare interventions: explanation and elaboration

Docetaxel and atrasentan versus docetaxel and placebo for men with advanced castration-resistant prostate cancer (SWOG S0421): a randomised phase 3 trial

Preliminary study of the specific endothelin a receptor antagonist zibotentan in combination with docetaxel in patients with metastatic castration-resistant prostate cancer.

Phase 3, randomized, controlled trial of atrasentan in patients with nonmetastatic, hormone-refractory prostate cancer.

Abiraterone for treatment of metastatic castration-resistant prostate cancer: a systematic review and meta-analysis.

Mechanisms leading to the development of hormone-resistant prostate cancer.

Cancer epidemiology in mainland South-East Asia - past, present and future.

Ten years of docetaxel-based therapies in prostate adenocarcinoma: a systematic review and meta-analysis of 2244 patients in 12 randomized clinical trials.

Immunotherapy and endothelin receptor antagonists for treatment of castration-resistant prostate cancer.

P304

e0133803

http://www.w3.org/2001/XMLSchema#string

P31

scholarly article

meta-analysis

P356

10.1371/JOURNAL.PONE.0133803

http://www.w3.org/2001/XMLSchema#string

P407

English

P433

http://www.w3.org/2001/XMLSchema#string

P478

http://www.w3.org/2001/XMLSchema#string

P577

2015-07-20T00:00:00Z

http://www.w3.org/2001/XMLSchema#dateTime

P5875

281821405

http://www.w3.org/2001/XMLSchema#string

P698

26192308

http://www.w3.org/2001/XMLSchema#string

P932

4508042

http://www.w3.org/2001/XMLSchema#string

A Meta-Analysis and Indirect Comparison of Endothelin A Receptor Antagonist for Castration-Resistant Prostate Cancer.

about

P2860

P2860

A Meta-Analysis and Indirect Comparison of Endothelin A Receptor Antagonist for Castration-Resistant Prostate Cancer.

description

name

type

label

prefLabel

P1433

P1476

P2093

P2860

P304

P31

P356

P407

P433

P478

P577

P5875

P698

P932

P356

P1433

P1476

P2093

P2860

P304

P31

P356

P407

P433

P478

P577

P5875

P698

P932